Instituto Rosenbusch

Instituto Rosenbusch Cash Ratio

Cash Ratio of Instituto Rosenbusch (ROSE2.BA) as of Oct 17, 2026.

Cash Ratio

-

Last updated:

Cash Ratio of Instituto Rosenbusch is 2026 - . Cash Ratio of Instituto Rosenbusch was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instituto Rosenbusch Stock analysis

What does Instituto Rosenbusch do? Instituto Rosenbusch SA, based in Buenos Aires, Argentina, operates in the Health Care sector, specifically in Pharmaceuticals. The company manufactures and markets veterinary products, including pharmaceuticals such as antibiotics, antimastitics, antimycotics, antiparasites, vitamins, and minerals, as well as biological products like vaccines for cattle, equines, pigs, sheep, and dogs. It also engages in meat slaughtering and provision. Listed on 21 February 2008, the company owns subsidiaries including Laboratorios Rosenbusch SA, Laboratorios Bolivar SA, and Rosenbusch Paraguay SA. Instituto Rosenbusch is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instituto Rosenbusch stock

On Eulerpool you can find the complete historical development of Cash Ratio Instituto Rosenbusch since 2006 – with annual values, charts, and detailed analysis.

The Cash Ratio is the most conservative liquidity metric, comparing only cash and equivalents to current liabilities.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Ratio's Instituto Rosenbusch with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Instituto Rosenbusch

All Key Metrics — Instituto Rosenbusch